iBio annual gross margin
2021
2022
iBio Gross Margin Growth & History (IBIO)
iBio's gross margin was 115.02% for fiscal 2022.
View full iBio company overviewiBio annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-06-30 | 115.02% | +76.68 pp |
| 2021 | 2021-06-30 | 38.34% | — |
iBio quarterly gross margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q3.22
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2022 | 2022-03-31 | 105.28% | +35.21 pp |
| Q1 2022 | 2021-09-30 | 203.57% | +129.67 pp |
| Q4 2021 | 2021-06-30 | −32.59% | — |
| Q3 2021 | 2021-03-31 | 35.56% | — |
| Q2 2021 | 2020-12-31 | 70.07% | — |
| Q1 2021 | 2020-09-30 | 73.90% | — |
iBio gross margin trends
Across the available reported history, iBio's gross margin increased from 38.34% to 115.02%, a change of +76.68 percentage points. The latest reported quarter, Q3 2022, shows 105.28%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review iBio filings at SEC.gov ↗